(Q40539790)

English

Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

Gerd Fätkenheuer

12

object named as

Gerd Fätkenheuer

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Oliver A Cornely

1

object named as

Oliver A Cornely

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Meinolf Karthaus

8

object named as

Meinolf Karthaus

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Thomas Wicke

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Harald Seifert

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ullrich Bethe

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Martin Schwonzen

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dietmar Reichert

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Andrew J Ullmann

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kai Breuer

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bernd Salzberger

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Volker Diehl

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

74-78

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Risk assessment and risk-based therapeutic strategies in febrile neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FBF02983537

21 January 2018

Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FBF02983537

21 January 2018

Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)

1 reference

https://api.crossref.org/works/10.1007%2FBF02983537

21 January 2018

Antimicrobial susceptibility of viridans group streptococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New uses for new and old quinolones and the challenge of resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14979482

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02983537

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40539790&oldid=2203770926"